Cargando…

Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity

CD47 serves as an anti-phagocytic receptor that is upregulated by cancer to promote immune escape. As such, CD47 is the focus of intense immuno-oncology drug development efforts. However, as CD47 is expressed ubiquitously, clinical development of conventional drugs, e.g., monoclonal antibodies, is c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dheilly, Elie, Majocchi, Stefano, Moine, Valéry, Didelot, Gérard, Broyer, Lucile, Calloud, Sébastien, Malinge, Pauline, Chatel, Laurence, Ferlin, Walter G., Kosco-Vilbois, Marie H., Fischer, Nicolas, Masternak, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698848/ https://www.ncbi.nlm.nih.gov/pubmed/31544856 http://dx.doi.org/10.3390/antib7010003

Ejemplares similares

Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
por: Dheilly, Elie, et al.
Publicado: (2017)

CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
por: Chauchet, Xavier, et al.
Publicado: (2022)

Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
por: Fischer, Nicolas, et al.
Publicado: (2015)

Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors
por: Hatterer, Eric, et al.
Publicado: (2020)

Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation
por: Hatterer, Eric, et al.
Publicado: (2019)

Interferon gamma (IFNg) production is associated to disease parameters in TLR9-induced secondary hemophagocytic lymphohistiocytosis (sHLH) in mice
por: De Min, Cristina, et al.
Publicado: (2014)

Interferon gamma (IFNg) drives disease in the TLR9-mediated cytokine storm syndrome in mice
por: de Min, C, et al.
Publicado: (2015)

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
por: Chen, Shih-Hsun, et al.
Publicado: (2021)

Transferring the Characteristics of Naturally Occurring and Biased Antibody Repertoires to Human Antibody Libraries by Trapping CDRH3 Sequences
por: Venet, Sophie, et al.
Publicado: (2012)

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody
por: Loyau, Jérémy, et al.
Publicado: (2014)

Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis
por: Buatois, Vanessa, et al.
Publicado: (2017)

Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment
por: Wang, Rongjuan, et al.
Publicado: (2023)

Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
por: Park, Ha-Ram, et al.
Publicado: (2022)

By-passing in vitro screening—next generation sequencing technologies applied to antibody display and in silico candidate selection
por: Ravn, U., et al.
Publicado: (2010)

Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
por: Yang, Yun, et al.
Publicado: (2023)

Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
por: Yang, Yan, et al.
Publicado: (2021)

Tuning Relative Polypeptide Expression to Optimize Assembly, Yield and Downstream Processing of Bispecific Antibodies
por: Magistrelli, Giovanni, et al.
Publicado: (2018)

Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice
por: Schmid, Jana Pachlopnik, et al.
Publicado: (2009)

Enhancing the antitumor potency of T cells redirected by bispecific antibodies
por: Chang, Chien-Hsing, et al.
Publicado: (2017)

Enhanced Follicular Dendritic Cell-B Cell Interaction in HIV and SIV Infections and its Potential Role in Polyclonal B Cell Activation
por: Rosenberg, Yvonne J., et al.
Publicado: (1998)

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
por: Yano, Hiroshi, et al.
Publicado: (2014)

Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
por: Lutz, Martina Svenja, et al.
Publicado: (2022)

Cell-type specific potent Wnt signaling blockade by bispecific antibody
por: Lee, Nam-Kyung, et al.
Publicado: (2018)

P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES
por: Grandclement, C., et al.
Publicado: (2022)

De novo isolation of antibodies with pH-dependent binding properties
por: Bonvin, Pauline, et al.
Publicado: (2015)

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation
por: Hendriks, Mark A. J. M., et al.
Publicado: (2020)

Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
por: Kobold, Sebastian, et al.
Publicado: (2018)

An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
por: Wang, Xinmin, et al.
Publicado: (2021)

Polyamine blockade promotes antitumor immunity
por: Hayes, Candace S, et al.
Publicado: (2014)

Germinal Center Formation and Local Immunoglobulin E (IgE) Production in the Lung after an Airway Antigenic Challenge
por: Chvatchko, Yolande, et al.
Publicado: (1996)

A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy
por: Satta, Alessandro, et al.
Publicado: (2019)

Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies
por: Kauer, Joseph, et al.
Publicado: (2020)

T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
por: Kamakura, Daisuke, et al.
Publicado: (2021)

Interleukin 6 Influences Germinal Center Development and Antibody Production via a Contribution of C3 Complement Component
por: Kopf, Manfred, et al.
Publicado: (1998)

The Sequential Role of Lymphotoxin and B Cells in the Development of Splenic Follicles
por: Gonzalez, Mercedes, et al.
Publicado: (1998)

CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors
por: Liu, Xiaojuan, et al.
Publicado: (2015)

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
por: Lin, Fangzhen, et al.
Publicado: (2021)

CD47 blockade enhances phagocytosis of cardiac cell debris by neutrophils
por: Haj-Yehia, Elias, et al.
Publicado: (2023)

¿Por qué mienten los niños? /
por: Broyer, Gérard, 1943-
Publicado: (1978)

CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
por: Xu, Ji-Feng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eehdjgaj7ufs26r9qeeha990k2